Institutional Ownership
Cullinan Therapeutics Inc
CUSIP 230031106COMCGEMQ1 2026
Institutional Holders
167
13F filers
Shares Held
62.13M
Aggregate institutional
Institutional Value
$850.46M
Q1 2026
Net New Holders
+18
33 new · 15 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions33
Increased61
Decreased42
Sold out15
Institutional Holders
167 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 8.96M | $127.37M | 0 | Held |
| 2 | Mpm Bioimpact LLC | 7.65M | $108.68M | 0 | Held |
| 3 | Bvf Inc/Il | 5.75M | $81.72M | 0 | Held |
| 4 | Blackrock, Inc. | 4.45M | $63.23M | +49.7K | Added |
| 5 | Kynam Capital Management, LP | 3.11M | $44.25M | 0 | Held |
| 6 | State Street Corp | 2.54M | $36.15M | +346.8K | Added |
| 7 | Blue Owl Capital Holdings LP | 1.91M | $27.14M | −441.2K | Reduced |
| 8 | Rtw Investments, LP | 1.71M | $24.24M | 0 | Held |
| 9 | Venrock Adviser, LLC | 1.38M | $19.61M | 0 | Held |
| 10 | Geode Capital Management, LLC | 1.37M | $19.45M | +66.0K | Added |
157 more institutional holders on Premium
See every fund holding Cullinan Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders